Semaglutide is a medication specifically designed to help manage type 2 diabetes
Hepatocellular carcinoma (HCC) often develops in the context of obesity-related liver disease, including nonalcoholic steatohepatitis (NASH)
An evidence-based update on the diagnosis and management of irritable bowel syndrome
Findings indicated that when added to standard care, semaglutide decreased the occurrence of a composite of cardiovascular-related deaths, non-fatal heart attacks, or non-fatal strokes over an average follow-up period of 39.8 9.4 months in this group compared to the placebo group
These include temporary skin reactions like redness and itching, rare allergic reactions, potential uneven skin tone, increased sun sensitivity, and concerns about liver function with high doses
In summary, sermorelin and ipamorelin provide notable benefits for stimulating growth hormone release, each with specific advantages